Aeglea Biotherapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.5M | 386k | 16.76 |
| 2025-06-30 | $6.9M | 463k | 14.97 |
| 2025-03-31 | $8.9M | 552k | 16.14 |
| 2024-12-31 | $9.1M | 392k | 23.28 |
| 2024-09-30 | $1.7M | 58k | 29.41 |
| 2024-06-30 | $1.0M | 45k | 23.51 |
| 2024-03-31 | $99k | 2.6k | 37.93 |
| 2023-12-31 | $80k | 3.7k | 21.52 |